Cargando…
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
It is well documented that dysregulation of microRNAs is a hallmark of human cancers. Thus, this family of small non-coding regulatory molecules represents an excellent source of sensitive biomarkers. Unique microRNAs expression profiles have been associated with different types and subsets of gastr...
Autores principales: | Vicentini, Caterina, Fassan, Matteo, D’Angelo, Edoardo, Corbo, Vincenzo, Silvestris, Nicola, Nuovo, Gerard J., Scarpa, Aldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271745/ https://www.ncbi.nlm.nih.gov/pubmed/24566314 http://dx.doi.org/10.3390/molecules19022458 |
Ejemplares similares
-
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine
por: Simbolo, Michele, et al.
Publicado: (2018) -
Current role of non-coding RNAs in the clinical setting
por: Vicentini, Caterina, et al.
Publicado: (2019) -
Exosomal miRNA signatures of pancreatic lesions
por: Vicentini, Caterina, et al.
Publicado: (2020) -
Mesenchymal tumours of the gastrointestinal tract
por: Sbaraglia, Marta, et al.
Publicado: (2021) -
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7
por: Cui, Ri, et al.
Publicado: (2015)